✦ LIBER ✦

Persistence of occult metastatic cells in bone marrow of breast cancer patients despite systemic adjuvant treatment

✍ Scribed by W. Janni; B. Rack; D. Rjosk; E. Klanner; C. Kentenich; C. Schindlbeck; S. Braun; H. Sommer

Book ID: 114315580
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 218 KB
Volume: 12
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(03)80055-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of systemic therapy on the per

Influence of systemic therapy on the persistence of occult metastatic cells in bone marrow of breast cancer patients

✍ W. Janni; B. Strobl; D. Rjosk; C. Kentenich; F. Hepp; C. Schindlbeck; H. Sommer; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Persistent occult metastatic cells in bo

Persistent occult metastatic cells in bone marrow of breast cancer patients may require antibody therapy

✍ W. Janni; B. Strobl; D. Rjosk; Ch. Kentenich; F. Hepp; Ch. Schindlbeck; H. Somme 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Clinical significance of proliferative p

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

✍ Pierga, J-Y; Bonneton, C; Magdelénat, H; Vincent-Salomon, A; Nos, C; Pouillart, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

Recent advances in technologies for the

Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients

✍ Stephan Braun, Nadia Harbeck 📂 Article 📅 2001 🏛 BioMed Central 🌐 English ⚖ 45 KB

Clinical Relevance of Occult Metastatic

Clinical Relevance of Occult Metastatic Cells in the Bone Marrow of Patients with Different Stages of Breast Cancer

✍ Wolfgang Janni; Dorothea Rjosk; Stephan Braun 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 385 KB

Monoclonal antibodies for detection of o

Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients

✍ Georgiana Ellis; Marina Ferguson; Elaine Yamanaka; Robert B. Livingston; Allen M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Metastases develop in 30% to 40% of patients with operable breast cancer. Investigators have reported on the detection of occult micrometastases in bone marrow using an antibody to epithelial membrane antigen (EMA) and have since reported prognostic significance for these antibody-detected cells. In